TECX vs TIL

Tectonic Therapeutic, Inc. vs Instil Bio, Inc. — Valuation Comparison 2026

TECX

Biological Products, (No Diagnostic Substances)
Tectonic Therapeutic, Inc.
Quality
4.3
out of 10
Value Trap
18
SAFE
Price
$31.16
Last close
Models
7/13
Active
VS

TIL

Biological Products, (No Diagnostic Substances)
Instil Bio, Inc.
Quality
4.4
out of 10
Value Trap
24
SAFE
Price
$8.07
Last close
Models
7/13
Active

Model-by-Model Comparison

ModelType TECX Fair ValueTECX Upside TIL Fair ValueTIL Upside
Bayesian DCF Intrinsic $14.60 -53.2% $2.54 -68.6%
First Chicago Scenario $•••.•• ••.•% $•••.•• ••.•%
ML-RIV Intrinsic $•••.•• ••.•% $•••.•• ••.•%
Dynamic NAV Asset-Based $18.11 -41.9% $12.91 +60.0%
PWERM Option-Based $•••.•• ••.•% $•••.•• ••.•%
Sentiment SOTP Hybrid $•••.•• ••.•% $•••.•• ••.•%
CUCE Ensemble Ensemble $•••.•• ••.•% $•••.•• ••.•%
🔒

Unlock Full 13-Model Comparison

Access all valuation models for TECX vs TIL — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

TECX vs TIL — Which Stock Is More Undervalued?

TIL scores higher with a 4.4/10 quality rating vs TECX's 4.3/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Tectonic Therapeutic, Inc. (TECX) and Instil Bio, Inc. (TIL) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

TECX currently trades at $31.16 with a QOC of 4.3/10, while TIL trades at $8.07 with a QOC of 4.4/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).